CHST15 抗体 (Middle Region)
-
- 抗原 See all CHST15 抗体
- CHST15 (Carbohydrate (N-Acetylgalactosamine 4-Sulfate 6-O) Sulfotransferase 15 (CHST15))
-
抗原表位
- Middle Region
-
适用
- 人, 大鼠, 小鼠
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This CHST15 antibody is un-conjugated
-
应用范围
- Western Blotting (WB)
- 特异性
- GALNAC4 S-4 T antibody was raised against the middle region of GALNAC4 -4 T
- 纯化方法
- Affinity purified
- 免疫原
- GALNAC4 S-4 T antibody was raised using the middle region of GALNAC4 -4 T corresponding to a region with amino acids YDNSTDGEPPFLTQDFIHAFQPNARLIVMLRDPVERLYSDYLYFASSNKS
- Top Product
- Discover our top product CHST15 Primary Antibody
-
-
- 应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - 说明
-
GALNAC4S-6ST Blocking Peptide, catalog no. 33R-10074, is also available for use as a blocking control in assays to test for specificity of this GALNAC4S-6ST antibody
- 限制
- 仅限研究用
-
- 状态
- Lyophilized
- 溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GALNAC0 -0 T antibody in PBS
- 浓度
- Lot specific
- 缓冲液
- PBS
- 注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - 储存条件
- 4 °C/-20 °C
- 储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- 抗原
- CHST15 (Carbohydrate (N-Acetylgalactosamine 4-Sulfate 6-O) Sulfotransferase 15 (CHST15))
- 别名
- GALNAC4S-6ST (CHST15 产品)
- 别名
- GALNAC4S-6ST antibody, BRAG antibody, RP11-47G11.1 antibody, 4631426J05Rik antibody, GalNAcS-6ST antibody, MAd5 antibody, mKIAA0598 antibody, GalNAc4S6ST antibody, Galnac4s-6st antibody, carbohydrate sulfotransferase 15 antibody, carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 antibody, CHST15 antibody, chst15 antibody, Chst15 antibody
- 背景
- GALNAC4S-6ST is a sulfotransferase that transfers sulfate from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to the C-6 hydroxyl group of the GalNAc 4-sulfate residue of chondroitin sulfate A and forms chondroitin sulfate E containing GlcA-GalNAc(4,6-SO(4)) repeating units. It also transfers sulfate to a unique non-reducing terminal sequence, GalNAc(4SO4)-GlcA(2SO4)-GalNAc(6SO4), to yield a highly sulfated structure similar to the structure found in thrombomodulin chondroitin sulfate. GALNAC4S-6ST may also act as a B-cell receptor involved in BCR ligation-mediated early activation that mediate regulatory signals key to B-cell development and/or regulation of B-cell-specific RAG expression, however such results are unclear in vivo.
- 分子量
- 65 kDa (MW of target protein)
- 途径
- Glycosaminoglycan Metabolic Process
-